The current status of blood fractionation in the United States.
D000951:Antigens, Neoplasm / Q000032:analysis; D000961:Antilymphocyte Serum; D001782:Blood Donors; D001798:Blood Proteins / Q000302:isolation & purification*; D001803:Blood Transfusion; D005164:Factor IX / Q000302:isolation & purification; D005169:Factor VIII / Q000302:isolation & purification; D006509:Hepatitis B / Q000517:prevention & control; D006511:Hepatitis B Antigens / Q000302:isolation & purification; D006801:Humans; D007136:Immunoglobulins / Q000302:isolation & purification; D007880:Legislation, Drug; D008722:Methods; D010920:Placenta / Q000032:analysis; D010949:Plasma / Q000032:analysis*; D010956:Plasmapheresis; D012709:Serum Albumin / Q000302:isolation & purification; D014481:United States
D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D001798:Blood Proteins; D006511:Hepatitis B Antigens; D007136:Immunoglobulins; D012709:Serum Albumin; D005169:Factor VIII; D005164:Factor IX